Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 4/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | ACE | P12821 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.54 |
| ▸ | BACE1 | P56817 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | MDM4 | O15151 | 1/20 | 0.51 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.51 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.51 |
| ▸ | CTSS | P25774 | 1/20 | 0.50 |
| ▸ | CTSK | P43235 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30064651 | 0.99 | CTSL (0.62) | CTSLGAARAB9AACETSHR | |
| SCHEMBL3935180 | 0.99 | CTSL (0.62) | CTSLGAARAB9AACETSHR | |
| SCHEMBL1796825 | 0.99 | CTSL (0.62) | CTSLGAARAB9AACETSHR | |
| SCHEMBL1784498 | 0.99 | CTSL (0.62) | CTSLGAARAB9AACETSHR | |
| SCHEMBL3927110 | 0.94 | CTSL (0.58) | CTSLGAARAB9AACETSHR | |
| SCHEMBL28790851 | 0.91 | CTSL (0.71) | CTSLGAARAB9AACEALDH1A1 | |
| SCHEMBL3927028 | 0.91 | CTSL (0.71) | CTSLGAARAB9AACEALDH1A1 | |
| SCHEMBL27761117 | 0.90 | CTSL (0.62) | CTSLGAARAB9AACEALDH1A1 | |
| SCHEMBL3928165 | 0.88 | LNPEP (0.67) | CTSLGAARAB9AACETSHR | |
| SCHEMBL3928164 | 0.88 | LNPEP (0.67) | CTSLGAARAB9AACETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0914167-B1 | METHOD OF PREVENTING SKIN IRRITATION CAUSED BY FECAL ENZYMES | SUED CHEMIE INC (US) | 2004-09-22 | — | — | EP | disclosed |
| EP-0914167-A4 | METHOD OF PREVENTING SKIN IRRITATION CAUSED BY FECAL ENZYMES | ENVIRODERM PHARMACEUTICALS INC (US) | 2001-12-19 | — | — | EP | disclosed |
| US-6331295-B1 | DIAPER RASH, INACTIVATING THE FECAL PROTEOLYTIC ENZYMES BY CONTACT WITH ORGANOPHILIC CLAY IN REACTION PRODUCT WITH A LONG CHAIN ORGANIC QUATERNARY AMMONIUM COMPOUND IN A MATRIX OF A SUPERABSORBENT POLYMER | ENVIRODERM PHARMACEUTICALS, INC. | 2001-12-18 | — | — | US | disclosed |
| US-6051749-A | COMPRISING WOWEN OR NON-WOVEN WEB HAVING ORGANIPHILIC CLAY INCORPORATED; FOR PREVENTING AND CONTACT DERMATITIS DUE TO FECAL ENZYMES | ENVIRODERM PHARMACEUTICALS INC. (US) | 2000-04-18 | — | — | US | disclosed |
| EP-0914167-A1 | METHOD OF PREVENTING SKIN IRRITATION CAUSED BY FECAL ENZYMES | Enviroderm Pharmaceuticals, Inc. (US) | 1999-05-12 | — | — | EP | disclosed |
| US-5869033-A | CONTACTING SKIN WITH ORGANOPHILIC CLAY, THE REACTION PRODUCT OF NATURAL OR SYNTHETIC CLAY WITH LONG CHAIN ORGANIC QUATERNARY AMMONIUM COMPOUND | ENVIRODERM PHARMACEUTICALS,INC. (US) | 1999-02-09 | — | — | US | disclosed |
| WO-1997038735-A1 | METHOD OF PREVENTING SKIN IRRITATION CAUSED BY FECAL ENZYMES | ENVIRODERM PHARMACEUTICALS, INC. (US) | 1997-10-23 | — | — | WO | disclosed |